1 Neuromodulation Devices Market Overview 1.1 Product Overview and Scope of Neuromodulation Devices 1.2 Neuromodulation Devices Segment by Type 1.2.1 Global Neuromodulation Devices Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Deep Brain Stimulation (DBS) 1.2.3 Spinal Cord Stimulation (SCS) 1.2.4 Vagus Nerve Stimulation (VNS) 1.2.5 Sacral Nerve Stimulation (SNS) 1.2.6 Gastric Electrical Stimulation (GES) 1.3 Neuromodulation Devices Segment by Application 1.3.1 Neuromodulation Devices Sales Comparison by Application: (2021-2027) 1.3.2 Pain Management 1.3.3 Parkinson’s Disease 1.3.4 Urinary and Fecal Incontinence 1.3.5 Epilepsy 1.3.6 Gastroparesis 1.3.7 Other 1.4 Global Neuromodulation Devices Market Size Estimates and Forecasts 1.4.1 Global Neuromodulation Devices Revenue 2016-2027 1.4.2 Global Neuromodulation Devices Sales 2016-2027 1.4.3 Neuromodulation Devices Market Size by Region: 2016 Versus 2021 Versus 2027 2 Neuromodulation Devices Market Competition by Manufacturers 2.1 Global Neuromodulation Devices Sales Market Share by Manufacturers (2016-2021) 2.2 Global Neuromodulation Devices Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Neuromodulation Devices Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Neuromodulation Devices Manufacturing Sites, Area Served, Product Type 2.5 Neuromodulation Devices Market Competitive Situation and Trends 2.5.1 Neuromodulation Devices Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Neuromodulation Devices Players Market Share by Revenue 2.5.3 Global Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Neuromodulation Devices Retrospective Market Scenario by Region 3.1 Global Neuromodulation Devices Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Neuromodulation Devices Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Neuromodulation Devices Market Facts & Figures by Country 3.3.1 North America Neuromodulation Devices Sales by Country 3.3.2 North America Neuromodulation Devices Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Neuromodulation Devices Market Facts & Figures by Country 3.4.1 Europe Neuromodulation Devices Sales by Country 3.4.2 Europe Neuromodulation Devices Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Neuromodulation Devices Market Facts & Figures by Region 3.5.1 Asia Pacific Neuromodulation Devices Sales by Region 3.5.2 Asia Pacific Neuromodulation Devices Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Neuromodulation Devices Market Facts & Figures by Country 3.6.1 Latin America Neuromodulation Devices Sales by Country 3.6.2 Latin America Neuromodulation Devices Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Neuromodulation Devices Market Facts & Figures by Country 3.7.1 Middle East and Africa Neuromodulation Devices Sales by Country 3.7.2 Middle East and Africa Neuromodulation Devices Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Neuromodulation Devices Historic Market Analysis by Type 4.1 Global Neuromodulation Devices Sales Market Share by Type (2016-2021) 4.2 Global Neuromodulation Devices Revenue Market Share by Type (2016-2021) 4.3 Global Neuromodulation Devices Price by Type (2016-2021) 5 Global Neuromodulation Devices Historic Market Analysis by Application 5.1 Global Neuromodulation Devices Sales Market Share by Application (2016-2021) 5.2 Global Neuromodulation Devices Revenue Market Share by Application (2016-2021) 5.3 Global Neuromodulation Devices Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Medtronic 6.1.1 Medtronic Corporation Information 6.1.2 Medtronic Description and Business Overview 6.1.3 Medtronic Neuromodulation Devices Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Medtronic Product Portfolio 6.1.5 Medtronic Recent Developments/Updates 6.2 Boston Scientific 6.2.1 Boston Scientific Corporation Information 6.2.2 Boston Scientific Description and Business Overview 6.2.3 Boston Scientific Neuromodulation Devices Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Boston Scientific Product Portfolio 6.2.5 Boston Scientific Recent Developments/Updates 6.3 Abbott 6.3.1 Abbott Corporation Information 6.3.2 Abbott Description and Business Overview 6.3.3 Abbott Neuromodulation Devices Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Abbott Product Portfolio 6.3.5 Abbott Recent Developments/Updates 6.4 LivaNova 6.4.1 LivaNova Corporation Information 6.4.2 LivaNova Description and Business Overview 6.4.3 LivaNova Neuromodulation Devices Sales, Revenue and Gross Margin (2016-2021) 6.4.4 LivaNova Product Portfolio 6.4.5 LivaNova Recent Developments/Updates 6.5 Nevro 6.5.1 Nevro Corporation Information 6.5.2 Nevro Description and Business Overview 6.5.3 Nevro Neuromodulation Devices Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Nevro Product Portfolio 6.5.5 Nevro Recent Developments/Updates 6.6 NeuroPace 6.6.1 NeuroPace Corporation Information 6.6.2 NeuroPace Description and Business Overview 6.6.3 NeuroPace Neuromodulation Devices Sales, Revenue and Gross Margin (2016-2021) 6.6.4 NeuroPace Product Portfolio 6.6.5 NeuroPace Recent Developments/Updates 6.7 Beijing Pins 6.6.1 Beijing Pins Corporation Information 6.6.2 Beijing Pins Description and Business Overview 6.6.3 Beijing Pins Neuromodulation Devices Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Beijing Pins Product Portfolio 6.7.5 Beijing Pins Recent Developments/Updates 6.8 Synapse Biomedical 6.8.1 Synapse Biomedical Corporation Information 6.8.2 Synapse Biomedical Description and Business Overview 6.8.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Synapse Biomedical Product Portfolio 6.8.5 Synapse Biomedical Recent Developments/Updates 7 Neuromodulation Devices Manufacturing Cost Analysis 7.1 Neuromodulation Devices Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Neuromodulation Devices 7.4 Neuromodulation Devices Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Neuromodulation Devices Distributors List 8.3 Neuromodulation Devices Customers 9 Neuromodulation Devices Market Dynamics 9.1 Neuromodulation Devices Industry Trends 9.2 Neuromodulation Devices Growth Drivers 9.3 Neuromodulation Devices Market Challenges 9.4 Neuromodulation Devices Market Restraints 10 Global Market Forecast 10.1 Neuromodulation Devices Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Neuromodulation Devices by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Neuromodulation Devices by Type (2022-2027) 10.2 Neuromodulation Devices Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Neuromodulation Devices by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Neuromodulation Devices by Application (2022-2027) 10.3 Neuromodulation Devices Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Neuromodulation Devices by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Neuromodulation Devices by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Neuromodulation Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Neuromodulation Devices Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Neuromodulation Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Neuromodulation Devices Covered in This Study Table 5. Global Neuromodulation Devices Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Neuromodulation Devices Sales Share by Manufacturers (2016-2021) Table 7. Global Neuromodulation Devices Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Neuromodulation Devices Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Neuromodulation Devices Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Neuromodulation Devices Manufacturing Sites and Area Served Table 11. Manufacturers Neuromodulation Devices Product Type Table 12. Global Neuromodulation Devices Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Neuromodulation Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromodulation Devices as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Neuromodulation Devices Sales by Region (2016-2021) & (K Units) Table 16. Global Neuromodulation Devices Sales Market Share by Region (2016-2021) Table 17. Global Neuromodulation Devices Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Neuromodulation Devices Sales by Country (2016-2021) & (K Units) Table 19. North America Neuromodulation Devices Sales Market Share by Country (2016-2021) Table 20. North America Neuromodulation Devices Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Neuromodulation Devices Revenue Market Share by Country (2016-2021) Table 22. Europe Neuromodulation Devices Sales by Country (2016-2021) & (K Units) Table 23. Europe Neuromodulation Devices Sales Market Share by Country (2016-2021) Table 24. Europe Neuromodulation Devices Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Neuromodulation Devices Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Neuromodulation Devices Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Neuromodulation Devices Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Neuromodulation Devices Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Neuromodulation Devices Revenue Market Share by Region (2016-2021) Table 30. Latin America Neuromodulation Devices Sales by Country (2016-2021) & (K Units) Table 31. Latin America Neuromodulation Devices Sales Market Share by Country (2016-2021) Table 32. Latin America Neuromodulation Devices Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Neuromodulation Devices Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Neuromodulation Devices Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Neuromodulation Devices Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Neuromodulation Devices Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Neuromodulation Devices Revenue Market Share by Country (2016-2021) Table 38. Global Neuromodulation Devices Sales (K Units) by Type (2016-2021) Table 39. Global Neuromodulation Devices Sales Market Share by Type (2016-2021) Table 40. Global Neuromodulation Devices Revenue (Million US$) by Type (2016-2021) Table 41. Global Neuromodulation Devices Revenue Share by Type (2016-2021) Table 42. Global Neuromodulation Devices Price (US$/Unit) by Type (2016-2021) Table 43. Global Neuromodulation Devices Sales (K Units) by Application (2016-2021) Table 44. Global Neuromodulation Devices Sales Market Share by Application (2016-2021) Table 45. Global Neuromodulation Devices Revenue (Million US$) by Application (2016-2021) Table 46. Global Neuromodulation Devices Revenue Share by Application (2016-2021) Table 47. Global Neuromodulation Devices Price (US$/Unit) by Application (2016-2021) Table 48. Medtronic Corporation Information Table 49. Medtronic Description and Business Overview Table 50. Medtronic Neuromodulation Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. Medtronic Neuromodulation Devices Product Table 52. Medtronic Recent Developments/Updates Table 53. Boston Scientific Corporation Information Table 54. Boston Scientific Description and Business Overview Table 55. Boston Scientific Neuromodulation Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Boston Scientific Neuromodulation Devices Product Table 57. Boston Scientific Recent Developments/Updates Table 58. Abbott Corporation Information Table 59. Abbott Description and Business Overview Table 60. Abbott Neuromodulation Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. Abbott Neuromodulation Devices Product Table 62. Abbott Recent Developments/Updates Table 63. LivaNova Corporation Information Table 64. LivaNova Description and Business Overview Table 65. LivaNova Neuromodulation Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. LivaNova Neuromodulation Devices Product Table 67. LivaNova Recent Developments/Updates Table 68. Nevro Corporation Information Table 69. Nevro Description and Business Overview Table 70. Nevro Neuromodulation Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 71. Nevro Neuromodulation Devices Product Table 72. Nevro Recent Developments/Updates Table 73. NeuroPace Corporation Information Table 74. NeuroPace Description and Business Overview Table 75. NeuroPace Neuromodulation Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 76. NeuroPace Neuromodulation Devices Product Table 77. NeuroPace Recent Developments/Updates Table 78. Beijing Pins Corporation Information Table 79. Beijing Pins Description and Business Overview Table 80. Beijing Pins Neuromodulation Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 81. Beijing Pins Neuromodulation Devices Product Table 82. Beijing Pins Recent Developments/Updates Table 83. Synapse Biomedical Corporation Information Table 84. Synapse Biomedical Description and Business Overview Table 85. Synapse Biomedical Neuromodulation Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 86. Synapse Biomedical Neuromodulation Devices Product Table 87. Synapse Biomedical Recent Developments/Updates Table 88. Production Base and Market Concentration Rate of Raw Material Table 89. Key Suppliers of Raw Materials Table 90. Neuromodulation Devices Distributors List Table 91. Neuromodulation Devices Customers List Table 92. Neuromodulation Devices Market Trends Table 93. Neuromodulation Devices Growth Drivers Table 94. Neuromodulation Devices Market Restraints Table 95. Global Neuromodulation Devices Sales Forecast by Type (2022-2027) & (K Units) Table 96. Global Neuromodulation Devices Sales Market Share Forecast by Type (2022-2027) Table 97. Global Neuromodulation Devices Revenue Forecast by Type (2022-2027) & (US$ Million) Table 98. Global Neuromodulation Devices Revenue Market Share Forecast by Type (2022-2027) Table 99. Global Neuromodulation Devices Sales Forecast by Application (2022-2027) & (K Units) Table 100. Global Neuromodulation Devices Sales Market Share Forecast by Application (2022-2027) Table 101. Global Neuromodulation Devices Revenue Forecast by Application (2022-2027) & (US$ Million) Table 102. Global Neuromodulation Devices Revenue Market Share Forecast by Application (2022-2027) Table 103. Global Neuromodulation Devices Sales Forecast by Region (2022-2027) & (K Units) Table 104. Global Neuromodulation Devices Sales Market Share Forecast by Region (2022-2027) Table 105. Global Neuromodulation Devices Revenue Forecast by Region (2022-2027) & (US$ Million) Table 106. Global Neuromodulation Devices Revenue Market Share Forecast by Region (2022-2027) Table 107. Research Programs/Design for This Report Table 108. Key Data Information from Secondary Sources Table 109. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Neuromodulation Devices Figure 2. Global Neuromodulation Devices Market Share by Type in 2020 & 2027 Figure 3. Deep Brain Stimulation (DBS) Product Picture Figure 4. Spinal Cord Stimulation (SCS) Product Picture Figure 5. Vagus Nerve Stimulation (VNS) Product Picture Figure 6. Sacral Nerve Stimulation (SNS) Product Picture Figure 7. Gastric Electrical Stimulation (GES) Product Picture Figure 8. Global Neuromodulation Devices Market Share by Application in 2020 & 2027 Figure 9. Pain Management Figure 10. Parkinson’s Disease Figure 11. Urinary and Fecal Incontinence Figure 12. Epilepsy Figure 13. Gastroparesis Figure 14. Other Figure 15. Global Neuromodulation Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Neuromodulation Devices Market Size 2016-2027 (US$ Million) Figure 17. Global Neuromodulation Devices Sales 2016-2027 (K Units) Figure 18. Global Neuromodulation Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 19. Neuromodulation Devices Sales Share by Manufacturers in 2020 Figure 20. Global Neuromodulation Devices Revenue Share by Manufacturers in 2020 Figure 21. The Global 5 and 10 Largest Neuromodulation Devices Players: Market Share by Revenue in 2020 Figure 22. Neuromodulation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 23. Global Neuromodulation Devices Sales Market Share by Region (2016-2021) Figure 24. Global Neuromodulation Devices Sales Market Share by Region in 2020 Figure 25. Global Neuromodulation Devices Revenue Market Share by Region (2016-2021) Figure 26. Global Neuromodulation Devices Revenue Market Share by Region in 2020 Figure 27. U.S. Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Canada Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Germany Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. France Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. U.K. Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Italy Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Russia Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. China Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Japan Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. South Korea Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. India Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Australia Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Taiwan Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Indonesia Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Thailand Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Malaysia Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Philippines Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Vietnam Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Mexico Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Brazil Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Argentina Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Turkey Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Saudi Arabia Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. UAE Neuromodulation Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. Sales Market Share of Neuromodulation Devices by Type (2016-2021) Figure 52. Sales Market Share of Neuromodulation Devices by Application (2016-2021) Figure 53. Sales Market Share of Neuromodulation Devices by Application in 2020 Figure 54. Revenue Share of Neuromodulation Devices by Application (2016-2021) Figure 55. Revenue Share of Neuromodulation Devices by Application in 2020 Figure 56. Manufacturing Cost Structure of Neuromodulation Devices Figure 57. Manufacturing Process Analysis of Neuromodulation Devices Figure 58. Neuromodulation Devices Industrial Chain Analysis Figure 59. Channels of Distribution Figure 60. Distributors Profiles Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Medtronic Boston Scientific Abbott LivaNova Nevro NeuroPace Beijing Pins Synapse Biomedical